These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 27701467)
1. Germline Variants of Prostate Cancer in Japanese Families. Hayano T; Matsui H; Nakaoka H; Ohtake N; Hosomichi K; Suzuki K; Inoue I PLoS One; 2016; 11(10):e0164233. PubMed ID: 27701467 [TBL] [Abstract][Full Text] [Related]
2. Germline genetic variants in men with prostate cancer and one or more additional cancers. Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667 [TBL] [Abstract][Full Text] [Related]
3. Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer. Hunter SM; Rowley SM; Clouston D; ; Li J; Lupat R; Krishnananthan N; Risbridger G; Taylor R; Bolton D; Campbell IG; Thorne H Urol Oncol; 2016 Mar; 34(3):120.e9-16. PubMed ID: 26585945 [TBL] [Abstract][Full Text] [Related]
4. Variants in Kurihara S; Matsui H; Ohtake N; Aoki M; Sekine Y; Arai S; Koike H; Suzuki K; Miyazawa Y Cancer Diagn Progn; 2022; 2(5):542-548. PubMed ID: 36060024 [TBL] [Abstract][Full Text] [Related]
5. Screening for familial and hereditary prostate cancer. Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190 [TBL] [Abstract][Full Text] [Related]
6. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men. Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563 [TBL] [Abstract][Full Text] [Related]
7. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy. Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701 [TBL] [Abstract][Full Text] [Related]
8. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
9. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients. Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in HOXB13 and prostate-cancer risk. Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224 [TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men. Heise M; Jarzemski P; Nowak D; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Borysiak M; Pilarska B; Haus O Cancer Control; 2022; 29():10732748211062342. PubMed ID: 35638715 [No Abstract] [Full Text] [Related]
12. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy. Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230 [TBL] [Abstract][Full Text] [Related]
13. Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer. Hart SN; Ellingson MS; Schahl K; Vedell PT; Carlson RE; Sinnwell JP; Barman P; Sicotte H; Eckel-Passow JE; Wang L; Kalari KR; Qin R; Kruisselbrink TM; Jimenez RE; Bryce AH; Tan W; Weinshilboum R; Wang L; Kohli M BMJ Open; 2016 Apr; 6(4):e010332. PubMed ID: 27084275 [TBL] [Abstract][Full Text] [Related]
14. Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls. Momozawa Y; Iwasaki Y; Hirata M; Liu X; Kamatani Y; Takahashi A; Sugano K; Yoshida T; Murakami Y; Matsuda K; Nakagawa H; Spurdle AB; Kubo M J Natl Cancer Inst; 2020 Apr; 112(4):369-376. PubMed ID: 31214711 [TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families. Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885 [TBL] [Abstract][Full Text] [Related]
16. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing. Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423 [TBL] [Abstract][Full Text] [Related]
17. A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation. Kosaka T; Hongo H; Aimono E; Matsumoto K; Hayashida T; Mikami S; Nishihara H; Oya M Pathol Int; 2019 Dec; 69(12):715-720. PubMed ID: 31631483 [TBL] [Abstract][Full Text] [Related]
18. Germline pathogenic variants in unselected Korean men with prostate cancer. So MK; Ahn HK; Huh J; Kim KH Investig Clin Urol; 2022 May; 63(3):294-300. PubMed ID: 35534218 [TBL] [Abstract][Full Text] [Related]
19. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674 [TBL] [Abstract][Full Text] [Related]
20. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers. Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]